SCHEMBL6258804

SCHEMBL6258804

CCc1cccc2c1C(=O)N(C(CCC(N)=O)C(=O)O)C2=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.57
MEN1 O00255 1/20 0.57
POLB P06746 4/20 0.54
ALDH1A1 P00352 3/20 0.54
MAPK1 P28482 2/20 0.54
KDM4E B2RXH2 1/20 0.54
TP53 P04637 1/20 0.54
GLA P06280 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
HPGD P15428 1/20 0.54
ALOX12 P18054 1/20 0.54
NFKB1 P19838 1/20 0.54
APEX1 P27695 1/20 0.54
HSD17B10 Q99714 1/20 0.54
GAA P10253 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.41
DNMT1 P26358 2/20 0.38
CYP2C19 P33261 1/20 0.38
DNMT3B Q9UBC3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6259531 0.92 KMT2A (0.54) KMT2AMEN1POLBALDH1A1MAPK1
SCHEMBL5025856 0.90 KMT2A (0.57) KMT2AMEN1POLBALDH1A1MAPK1
SCHEMBL6257297 0.90 KMT2A (0.52) KMT2AMEN1POLBALDH1A1MAPK1
SCHEMBL2167853 0.88 KMT2A (0.60) KMT2AMEN1POLBALDH1A1MAPK1
SCHEMBL6259357 0.88 ALDH1A1 (0.45) KMT2AMEN1POLBALDH1A1MAPK1
SCHEMBL29790446 0.86 KMT2A (0.61) KMT2AMEN1POLBALDH1A1MAPK1
SCHEMBL672662 0.86 KMT2A (0.61) KMT2AMEN1POLBALDH1A1MAPK1
SCHEMBL2168383 0.86 KMT2A (0.61) KMT2AMEN1POLBALDH1A1MAPK1
SCHEMBL6259576 0.85 ALDH1A1 (0.54) KMT2AMEN1POLBALDH1A1MAPK1
SCHEMBL6270550 0.85 ALDH1A1 (0.58) KMT2AMEN1POLBALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163219-B1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORP (US) 2005-10-12 EP disclosed
US-6380239-B1 FOR THERAPY OF ARTHRITIS, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, REPERFUSION INJURY, INFLAMMATORY BOWEL DISEASE, CROHN'S DISEASE, ULCERATIVE COLITIS, SYSTEMIC LUPUS ERYTHREMATOSIS, SCLERODERMA, APHTHOUS ULCERS, ASTHMA CELGENE CORPORATION 2002-04-30 US disclosed
CN-1342146-A Substituted 1-oxo-and 1, 3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels CELGENE CORP (US) 2002-03-27 CN disclosed
EP-1163219-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2001-12-19 EP disclosed
WO-2000055134-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2000-09-21 WO disclosed